Beth Schurman

Beth Schurman is Partner at Herspiegel Consulting.

Articles

Pharmaceutical Executive

Framework for FDA’s Real-World Evidence Program

The FDA proposes to use the RWE Program to guide generation of data in support of approval for new indications or to help support post-approval study requirements.